|
|
|
|
|
Bioterrorism Training Module (Print)
|
 |
|
|
|
|
|
|
|
Update yourself with essential medical information with this succinct 16-page print compilation of expert commentary and analyses of peer-reviewed literature. Focusing on six key agents -- botulism, viral hemorrhagic fever, anthrax, plague, tularemia and smallpox -- this up to date, need-to-know information can assist you in the diagnosis and treatment of diseases associated with bioterrorist assaults.
Intended Audience: Physicians interested in learning symptoms and treatment for exposure to biological agents.
Educational Objectives: This activity is designed to provide the participant with an overview and critical analysis of the most current, clinically useful information available in the journal literature covering biological agents.
Notice About Off-Label Use Presentations: The Johns Hopkins University School of Medicine activity entitled Bioterrorism Training Module may include presentations on drugs or devices, or uses of drugs or devices, which have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice and make meaningful disclosure to the audience.
Johns Hopkins University School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in the program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.
The following speakers have indicated that they have/have not received financial support for consultation, research, evaluation or have a financial interest relevant to their presentation. The following faculty are currently serving, or have served in the last three years as a Consultant for the following companies: Dr. Perl: Glaxo-Smith-Kline and 3-M Corp. The following faculty are currently serving, or have served in the last three years as a member of a Speaker’s Bureau for the following companies: Dr. Perl reports: Glaxo-Smith-Kline, Wyeth, and Pharmacia. The following faculty are receiving, or have received in the last three years, Grant/Research support from the following companies: Dr. Perl: Glaxo-Smith-Kline and Bristol-Myers-Squibb. The following faculty report No Conflicts: Doctors Borio, Bollinger, Dennis, and Arnon. The following faculty have not made disclosures as of the publication date: Srinivasan and Peters.
Accreditation Statement:
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this activity.
The opinions expressed within are those of the authors and do not necessarily represent the views of the sponsor, The Johns Hopkins University School of Medicine, or the publisher, Oakstone Medical Publishing. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
|
|
|
